Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
If you had invested $10,000 during Regeneron Pharmaceuticals' (NASDAQ: REGN) inception in the 1990s, that investment would have turned into more than $317,000 as of Jan. 11, 2021. That is a staggering outperformance compared to the S&P 500's 1,310% return during the same period. What's more, despite all the turmoil in the markets in 2020, Regeneron has jumped another 32% over the last 12 months.
Given this rate of return, Regeneron stock can turn investors into millionaires based on a small investment after one or two more decades. Today, let's look at why its shares are a fantastic buy-and-hold option for the long term.
Image source: Getty Images.
Source Fool.com
